Items where authors include "Barlesi, F."

Article

Wysocki, O. orcid.org/0000-0002-7053-4919, Zhou, C. orcid.org/0000-0002-6938-4685, Rogado, J. orcid.org/0000-0002-9795-8762 et al. (71 more authors) (2022) An international comparison of presentation, outcomes and CORONET predictive score performance in patients with cancer presenting with COVID-19 across different pandemic waves. Cancers, 14 (16). 3931. ISSN 2072-6694

Le Pechoux, C., Pourel, N., Barlesi, F. et al. (25 more authors) (2022) Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART, IFCT 0503): an open-label, randomised, phase 3 trial. The Lancet Oncology, 23 (1). pp. 104-114. ISSN 1470-2045

Chouaid, C., Danson, S. orcid.org/0000-0002-3593-2890, Andreas, S. et al. (15 more authors) (2018) Adjuvant treatment patterns and outcomes in patients with stage IB-IIIA non-small cell lung cancer in France, Germany, and the United Kingdom based on the LuCaBIS burden of illness study. Lung Cancer, 124. pp. 310-316. ISSN 0169-5002

Andreas, S., Chouaid, C., Danson, S. orcid.org/0000-0002-3593-2890 et al. (15 more authors) (2018) Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS). Lung Cancer, 124. pp. 298-309.

Faivre-Finn, C., Snee, M., Ashcroft, L. et al. (17 more authors) (2017) Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial. The Lancet Oncology, 18 (8). pp. 1116-1125. ISSN 1470-2045